Back to LPCN

UBS Group AG → LPCN

UBS Group AG LPCN Position History

Lipocine Inc. • Healthcare

Quarters held
9
Latest value
$3K
Q3 2026
Peak value
$45K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$9
Q3 2025$5K
Q4 2025$45K
Q1 2026$28K
Q1 2026$64
Q2 2026$6K
Q2 2026$3K
Q3 2026$5K
Q3 2026$3K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3K1.3K——
Q3 2026$5K2.2K——
Q2 2026$3K1.3K——
Q2 2026$6K2.3K——
Q1 2026$648——
Q1 2026$28K3.5K——
Q4 2025$45K5.6K——
Q3 2025$5K1.8K——
Q3 2025$93——

Other funds holding LPCN

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B